At the recent Israel Investment Seminar in New York, Yossi Beinart, head of the Tel Aviv Stock Exchange, spoke of plans to attract investors, including a move to allow Israeli companies to adopt Generally Accepted Accounting Procedures, or GAAP.In addition, the exchange, in conjunction with BlueStar Indexes, announced the TASE-BlueStar Israel Global Technology Index, which will track 57 major technology […]
Stock Market About Ready to Plunge!By: Brad Gudgeon | Sat, Mar 28, 2015SharePrintEmailLast time, I talked about there being one more rally left and then the market would drop big. I see no change in that outlook (after looking over the Gann Cycles from last Monday, I have determined that the next top would be April 2). I also talked […]
Pedro Castellano | Getty ImagesInvestors are bailing on biotech stocks at such a rapid pace that it is shocking even some of the most-seasoned traders. It’s a popping bubble that could have implications on the sustainability of this six-year bull market.Consider this, the most popular ETF in the sector—the Nasdaq Biotechnology iShares (IBB)—hit an all-time intraday high Friday of $374.62. […]
After an incredible run, investors are finally seeing some pain in the biotech and broader health care sector. Major biotechnology indexes were off over 4% in Wednesday trading, while the short term trend has not been favorable either.Some investors may now think that the bubble has burst for the high growth biotech sector, but there are actually still a few […]
Myles Udland
Mar. 25, 2015, 2:55 PM
2,734
Flickr/Gonzalo IzaBiotech investors have been here before.Stocks are lower on Wednesday and the high-flying biotech sector is leading the way down, with the iShares ETF that tracks the sector falling more than 3%. And as the sector has weakened over the last several days, this sell off is starting to look at lot like the sell […]
It’s been an eventful week on the pipeline front with companies like Biogen (BIIB – Analyst Report), Prothena (PRTA – Snapshot Report) and Vertex (VRTX – Analyst Report) coming out with data. Meanwhile, Gilead (GILD – Analyst Report) was back in the news once again due to its hepatitis C virus (HCV) franchise.Recap of the Week’s Most Important Stories1. Hopes […]
Biotech stocks have been on fire in 2015. In the Biotech & Pharmaceuticals sector of the Russell 2000 Growth Index, there are over sixty stocks up by more than 30% this year. More than thirty stocks are up greater than 50% while six have more than doubled.The iShares Biotechnology ETF (IBB) is already up more than 20% less than 3 […]
The multiyear run in major biotech stocks has not let up in 2015. Most of the large and mid-cap stocks in the industry are higher, but the smaller and lesser known names have also tracked them higher. In fact, several biotechs are up 200% or more so far in 2015.24/7 Wall St. ran a screen for the top five biotech […]
The multiyear run in major biotech stocks has not let up in 2015. Most of the large and mid-cap stocks in the industry are higher, but the smaller and lesser known names have also tracked them higher. In fact, several biotechs are up 200% or more so far in 2015.24/7 Wall St. ran a screen for the top five biotech […]
The stock has even more upside from where it was trading Friday, around $475 per share, Yaron Werber, senior biotech analyst at Citi Investment Research, told “Power Lunch.” As the Alzheimer’s drug likely will not reach the market for years, it is important to Biogen’s long-term prospects, he said.When looking at valuations, investors need to consider that low interest rates […]
